Comprehensive Study Guide: Microbes in Human Health (Fall 2024)

Principles of Human-Microbe Relationships and Symbiosis

Symbiosis is defined as the intimate and protracted association between two or more different biological species. Within this relationship, a symbiont is any organism that lives in such an association. A common misconception is that a symbiotic relationship is always a beneficial relationship; however, this is not the case. Symbiosis is a spectrum of interactions that can be beneficial, neutral, or harmful to the organisms involved. The human-microbe relationship is discussed as a spectrum because the nature of the association can shift depending on the context of the host's health and the environment. This spectrum includes mutualism, commensalism, and parasitism.

A mutualist, or an organism involved in mutualism, is a symbiont that provides a benefit to the host while also receiving a benefit in return. Conversely, a commensal, or an organism involved in commensalism, is one where the microbe benefits while the human host is neither helped nor harmed in any significant way. On the more negative end of the spectrum are pathogens and parasites. A parasite is an organism that lives on or in a host and gets its food from or at the expense of its host. A pathogen is a specific type of parasite—typically a microbe—that causes disease in its host. Certain bacteria are categorized based on their roles: an example of a bacteria that is considered "always" a pathogen in many clinical contexts is discussed in the curriculum, while others are characterized as "always" mutualists. Some bacteria, however, are versatile and can play multiple roles as a symbiont, acting as commensals in one person and pathogens in another. Evolution and adaptation play critical roles in these relationships, as microbes adapt to the host environment to ensure their own survival, sometimes leading to attenuated virulence or increased mutualistic cooperation.

The Human Microbiome and Colonization Dynamics

The human microbiome is a term used to describe the collective genomes of the microorganisms that reside in an environmental niche, though terms like "normal flora," "microbiota," or "commensals" are also frequently employed. Microorganisms colonize various body regions, including the skin, the gastrointestinal tract, the respiratory tract, and the urogenital tract. These colonized regions are categorized by their population density and stability: some are highly colonized with stable populations, while others are lightly colonized or contain transient populations that do not establish long-term residency. In contrast, certain body regions are considered sterile, such as the blood, the brain, and the lower reproductive tract (though this is subject to ongoing research). Some regions remain controversial regarding their sterility, such as the lungs and the placenta.

The colonization of the newborn human begins during and immediately after birth. The method of delivery is a significant factor; preliminary research on C-section deliveries shows that infants delivered via surgery may have a microbiome that more closely resembles the mother's skin rather than the vaginal flora encountered during a natural birth. Breastfeeding is of paramount importance for the infant microbiome because human milk contains human milk oligosaccharides (HMOs). HMOs are complex sugars that are not digestible by the infant but serve as a primary metabolic substrate for specific beneficial gut bacteria, thereby shaping the early microbial community. To identify and study the microbiome, scientists use advanced molecular tools such as 16S16S rRNA sequencing and metagenomic analysis. These tools allow researchers to understand the complex interactions involved in microbial antagonism, where established microbes inhibit the growth of others, and colonization resistance, the mechanism by which the existing microbiota protects the host against invasion by exogenous pathogens. This is often achieved through competitive exclusion, where microbes compete for limited nutrients and physical space, effectively blocking pathogens from establishing a foothold.

The Skin Microbiome: Composition and Defense

The skin microbiota serves three major roles: protecting the host from pathogens, training the immune system, and breaking down natural products. The skin surface is not entirely colonized; instead, it is a mosaic of micro-habitats. At a microscopic level, microbes are found primarily in the superficial layers of the stratum corneum and within the hair follicles and sweat glands. The environmental variables influencing bacterial growth on the skin include moisture levels, temperature, pH, and the concentration of lipids. Compared to the gut, the skin is considered a low nutrient environment. The primary source of nutrients for skin bacteria includes sebum (oils produced by sebaceous glands), sweat, and skin cell debris. Consequently, the metabolism found in skin bacteria is typically adapted to these substrates, often involving the fermentation of lipids or the breakdown of urea.

There are four primary habitats on human skin: oily (sebaceous), moist, dry, and foot. Skin microbiomes vary significantly between individuals, though an adult's skin microbiome is remarkably stable from month to month. The skin microbiome is dominated by bacteria, with the major fungal symbiont being the genus Malassezia. The bacterial symbionts vary by habitat: Propionibacterium (now Cutibacterium) species dominate oily areas, while Staphylococcus and Corynebacterium species are found in moist areas. Infants acquire their skin microbiome during birth and through contact with caregivers. A major shift occurs at puberty when hormonal changes increase sebum production, providing more nutrients for sebaceous-loving bacteria like Cutibacterium acnes. Early exposure to skin bacteria is essential for the development of the immune system, specifically for the induction of regulatory T cells which help prevent chronic inflammation.

Colonization resistance on the skin is exemplified by the control of Staphylococcus aureus. Staphylococcus epidermidis and other coagulase-negative Staphylococci play a vital role in colonization resistance by producing antimicrobial peptides (AMPs) that inhibit S. aureus. Propionibacterium contributes by producing fermented organic acids that lower the skin pH, making it inhospitable for many pathogens. Corynebacterium species also engage in niche competition. Dysbiosis, or a microbial imbalance, can lead to conditions like eczema or acne. Research into Staphylococcus epidermidis shows it is a complex mutualist that can also play potentially pathogenic roles, especially in hospital settings where it can form biofilms on medical devices. However, on balance, S. epidermidis is generally considered a mutualist on healthy skin. Similarly, Propionibacterium (or Cutibacterium) colonizes deep within the pores, utilizing sebum as a nutrient source.

The Gut Microbiome: Structure, Function, and Health

The gastrointestinal tract is colonized from the mouth to the rectum, with the highest colonization density occurring in the large intestine (colon). It is estimated that approximately 101310^{13} to 101410^{14} microbes reside in the human intestines. The colon habitat is structured into different compartments: the lumen (the center of the tube), the outer mucus layer, and the inner mucus layer. Bacterial numbers are highest in the lumen and the outer mucus layer, whereas the inner mucus layer is relatively sparse to prevent direct contact between bacteria and gut epithelial cells. Throughout the digestive tract, oxygen levels decrease significantly, creating an anaerobic environment in the colon. Therefore, the metabolism in the colon is primarily anaerobic fermentation, leading to the production of Short-Chain Fatty Acids (SCFAs) like butyrate, propionate, and acetate. SCFAs are crucial for human health as they provide energy for colonocytes, regulate inflammation, and influence systemic metabolism.

Throughout life, the microbiome undergoes changes: the number of species increases from infancy to adulthood, and the stability of the microbiome improves significantly in adulthood compared to the highly dynamic nature of the childhood microbiome. During times of stress or illness, bacteria in the mucus layer serve as a reservoir to maintain and restore the gut population. To interact with gut cells, bacteria use structures such as pili, fimbriae, and flagella. The host responds differently to commensals versus pathogens; commensals typically trigger immune tolerance, while pathogens trigger an inflammatory response. The gut microbiome impacts the immune system by aiding in the development of Gut-Associated Lymphoid Tissue (GALT). Antibiotics can significantly disrupt this balance, often leading to a loss of diversity. Fecal transplants involve the transfer of fecal matter from a healthy donor to a patient, meant to restore colonization resistance and treat recurrent infections like Clostridioides difficile.

Recent research indicates that human genetics impact the makeup of the microbiome, particularly through "highly heritable taxa." A highly heritable taxon is a group of microbes whose presence and abundance are influenced by the host's genetic background, often inherited through families. One such taxon is Christensenella. Christensenella is a mutualist associated with a lean body mass index (BMI); it uses anaerobic metabolism to break down complex carbohydrates and interacts with other microbes like methanogens in the gut. Akkermansia muciniphila is another critical symbiont that lives in the mucus layer, using mucus as a primary source of nutrients. By degrading mucus, Akkermansia produces SCFAs as byproducts and stimulates the host to produce more mucus, thereby strengthening the gut barrier and interacting positively with the immune system. A decrease in Akkermansia is linked to obesity and Type 2 diabetes. Lactobacillus species are also vital, using specialized S-layer proteins or pili to interact with the intestines and promote health. Bifidobacterium is dominant in infancy due to its ability to metabolize HMOs and remains important in adults for maintaining gut barrier integrity. Links between the gut microbiome and metabolic diseases like diabetes and obesity are increasingly supported by clinical research, suggesting that dysbiosis contributes to systemic low-grade inflammation.

Vaginal and Nasal Microbiota

The vagina is a unique microbial habitat characterized by a relatively low diversity of organisms compared to the gut. There are two general "types" of vaginal microbiomes: those dominated by Lactobacillus species and those with a more diverse array of anaerobic bacteria. Research has shown that these types can relate to ethnicity and genetic factors. Lactobacillus plays a crucial metabolic role by fermenting glycogen into lactic acid, which lowers the pH of the vagina to approximately 3.53.5 to 4.54.5. This acidic environment is a form of competitive exclusion that prevents the overgrowth of pathogens like Candida albicans (yeast). During pregnancy, the vaginal microbiome typically decreases in diversity and becomes even more dominated by Lactobacillus, which is thought to be an evolutionary mechanism to ensure the infant is colonized with beneficial bacteria during birth.

The human nasal microbiota also involves complex symbiotic relationships. The composition of the nasal microbiome has been shown to correlate with the severity of viral respiratory infections; individuals with certain microbial profiles may experience less severe symptoms. The nasal microbiome changes over time, with childhood profiles being distinct from adult profiles. In children, the nasal passage is often colonized by a wider variety of bacteria, including Moraxella and Streptococcus, whereas adult nasal microbiotas tend to stabilize with higher proportions of Corynebacterium and Staphylococcus species.